Pembrolizumab‑induced aseptic meningitis in a patient with non‑small cell lung cancer: A case report and literature review of aseptic meningitis as an immune‑related adverse event-Reference-Cited by-同舟云学术

Pembrolizumab‑induced aseptic meningitis in a patient with non‑small cell lung cancer: A case report and literature review of aseptic meningitis as an immune‑related adverse event

Published:2022-06-01 Issue:1 Volume:17 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Inui Genki¹,Funaki Yoshihiro¹,Makino Haruhiko¹,Touge Hirokazu²,Arai Katsunori¹,Kuroda Keisuke¹,Hirayama Yuuki¹,Kato Ryohei¹,Nonaka Takafumi¹,Yamane Kohei¹,Teruya Yasuhiko¹,Sueda Yuriko¹,Sakamoto Tomohiro¹,Yamaguchi Kosuke¹,Kodani Masahiro¹,Kawase Shinya³,Umekita Yoshihisa⁴,Horie Yasushi⁴,Nosaka Kanae⁴,Yamasaki Akira¹

Affiliation:

1. Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago, Tottori 683‑8503, Japan

2. Department of Respiratory Medicine, Yonago Medical Center, Yonago, Tottori 683‑0006, Japan

3. Department of Brain and Neurosciences, Division of Neurology, and 4Department of Pathology, Division of Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683‑8503, Japan

4. Department of Pathology, Division of Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683‑8503, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference34 articles.

1. NCCN guidelines insights: Non-small cell lung cancer, version 1.2020;Ettinger;J Natl Compr Canc Netw,2019

2. Neurological complications of immune checkpoint inhibitors: What happens when you ‘take the brakes off’ the immune system;Dalakas;Ther Adv Neurol Disord,2018

3. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline;Brahmer;J Clin Oncol,2018

4. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

5. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC;Socinski;N Engl J Med,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review;Pharmaceuticals;2023-08-09

2. Pembrolizumab;Reactions Weekly;2022-07